BEUDAMED
    3,822 results · 44ms · Sources: EU EUDAMED, US FDA

    Nagor Limited

    Device
    EU MDD · Eu Md Class 3 ·Nagor Limited·On the market·32 countries

    Nagor Limited

    Device
    EU MDD · Eu Md Class 3 ·Nagor Limited·On the market·32 countries

    Nagor Limited

    Device
    EU MDD · Eu Md Class 3 ·Nagor Limited·On the market·32 countries

    Nagor Limited

    Device
    EU MDD · Eu Md Class 3 ·Nagor Limited·On the market·32 countries

    Nagor Limited

    Device
    EU MDD · Eu Md Class 3 ·Nagor Limited·On the market·32 countries

    Nagor Limited

    Device
    EU MDD · Eu Md Class 3 ·Nagor Limited·On the market·32 countries

    Nagor Limited

    Device
    EU MDD · Eu Md Class 3 ·Nagor Limited·On the market·32 countries

    Nagor Limited

    Device
    EU MDD · Eu Md Class 3 ·Nagor Limited·On the market·32 countries

    Nagor Limited

    Device
    EU MDD · Eu Md Class 3 ·Nagor Limited·On the market·32 countries

    Nagor Limited

    Device
    EU MDD · Eu Md Class 3 ·Nagor Limited·On the market·32 countries

    Nagor Limited

    Device
    EU MDD · Eu Md Class 3 ·Nagor Limited·On the market·32 countries

    Advanced LumFix Spinal Fixation System

    FDA 510(k)
    FDA Class 2 ·Orthopedic

    Microscope column OPMI 9 FC (S 61 Servant)

    Basic UDI-DI
    EU MDR · Eu Md Class 1 ·ATMOS MedizinTechnik GmbH & Co. KG·1 device

    The Parkinsons KinetiGraph (PKG) System

    Basic UDI-DI
    EU MDR · Eu Md Class 2a ·GKC Manufacturing Pty. Ltd.·3 devices

    Test, Prostate Specific Antigen, Free, (Noncomplexed) To Distinguish Prostate Cancer From Benign Conditions

    FDA Pre-Market Approval
    FDA Class 3 ·DIMENSION FPSA FLEX REAGENT CARTRIDGE

    Test, Prostate Specific Antigen, Free, (Noncomplexed) To Distinguish Prostate Cancer From Benign Conditions

    FDA Pre-Market Approval
    FDA Class 3 ·Dimension Vista FPSA Flex reagent cartridge (K6452)

    Test, Prostate Specific Antigen, Free, (Noncomplexed) To Distinguish Prostate Cancer From Benign Conditions

    FDA Pre-Market Approval
    FDA Class 3 ·Dimension FPSA Flex Reagent Cartridge

    Test, Prostate Specific Antigen, Free, (Noncomplexed) To Distinguish Prostate Cancer From Benign Conditions

    FDA Pre-Market Approval
    FDA Class 3 ·DIMENSION FPSA FLEX REAGENT CARTRIDGE AND DIMENSION VISTA FPSA FLEX REAGENT CARTRIDGE

    Test, Prostate Specific Antigen, Free, (Noncomplexed) To Distinguish Prostate Cancer From Benign Conditions

    FDA Pre-Market Approval
    FDA Class 3 ·DIMENSION FPSA FLEX REAGENT CARTRIDGE

    Test, Prostate Specific Antigen, Free, (Noncomplexed) To Distinguish Prostate Cancer From Benign Conditions

    FDA Pre-Market Approval
    FDA Class 3 ·Dimension FPSA Flex reagent cartridge (RF451)